APA (7th ed.) Citation

AC, H., A, P., & ME, S. (2020). The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective. The Journal of infectious diseases, 221(Suppl 1), S109. https://doi.org/10.1093/infdis/jiz389

Chicago Style (17th ed.) Citation

AC, Hodowanec, Pikis A, and Singer ME. "The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective." The Journal of Infectious Diseases 221, no. Suppl 1 (2020): S109. https://doi.org/10.1093/infdis/jiz389.

MLA (9th ed.) Citation

AC, Hodowanec, et al. "The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective." The Journal of Infectious Diseases, vol. 221, no. Suppl 1, 2020, p. S109, https://doi.org/10.1093/infdis/jiz389.